FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

MINOGUE MICHAEL R		 2. Issuer Name and Ticker or Trading Symbol

ABIOMED INC [ ABMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chairman, President, CEO
(Last)          (First)          (Middle)

C/O ABIOMED, INC.,, 22 CHERRY HILL DRIVE		 3. Date of Earliest Transaction (MM/DD/YYYY)

5/15/2020
(Street)

DANVERS, MA 01923
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock $.01 par value 5/15/2020  F(5)  8506 (5)D$184.27 229303 D  
Common Stock $.01 par value 5/15/2020  F(5)  2063 (5)D$184.27 227240 D  
Common Stock $.01 par value 5/16/2020  F(5)  1632 (5)D$184.92 225608 D  
Common Stock $.01 par value 5/16/2020  F(5)  4546 (5)D$184.92 221062 D  
Common Stock $.01 par value         31672 I By Trust - A 
Common Stock $.01 par value         32810 I By Trust - C 
Common Stock $.01 par value         73745 I By Trust - B 
Common Stock $.01 par value         655 I By Trust - D 
Common Stock $.01 par value         38560 I By Trust - E 
Common Stock $.01 par value         85040 I By Trust - F 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) (2)$22.44           5/22/2013 (1)5/22/2022 Common Stock 0  100000 D  
Stock Option (Right to Buy) (2)$23.15           5/14/2014 (1)5/14/2023 Common stock 0  85000 D  
Stock Option (right to buy) (2)$21.55           5/14/2015 (3)5/14/2024 Common Stock 0  85000 D  
Stock Option (right to buy) (2)$66.25           5/13/2016 (3)5/13/2025 Common Stock 0  35000 D  
Stock Option (right to buy) (4)$99.62           5/24/2017 (3)5/24/2026 Common Stock 0  30500 D  
Stock Option (right to buy) (4)$134.51           5/15/2018 (3)5/15/2027 Common Stock 0  33000 D  
Stock Option (right to buy) (4)$381.97           5/16/2019 (3)5/16/2028 Common Stock 0  30000 D  
Stock Option (right to buy) (4)$266.39           5/30/2020 (3)5/30/2029 Common Stock 0  50000 D  
Explanation of Responses:
(1) These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
(2) Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
(3) These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
(4) Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
(5) Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
MINOGUE MICHAEL R
C/O ABIOMED, INC.,
22 CHERRY HILL DRIVE
DANVERS, MA 01923		X
Chairman, President, CEO
Signatures
/s/ Ian W. McLeod (by power of attorney)5/19/2020
**Signature of Reporting PersonDate
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ABIOMED Charts.
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ABIOMED Charts.